PETS Stock Overview
Operates as a pet pharmacy in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
PetMed Express, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.97 |
| 52 Week High | US$7.79 |
| 52 Week Low | US$2.90 |
| Beta | 0.71 |
| 1 Month Change | 8.52% |
| 3 Month Change | 42.00% |
| 1 Year Change | -33.91% |
| 3 Year Change | -81.16% |
| 5 Year Change | -78.52% |
| Change since IPO | 297.60% |
Recent News & Updates
PetMed Express: Why (And Why Not) The Rebound Could Continue
Nov 12Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
Oct 04
Recent updates
PetMed Express: Why (And Why Not) The Rebound Could Continue
Nov 12Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
Oct 04PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 09PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
Jun 14PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Jun 12A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Oct 09PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
Aug 07The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
Mar 23PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Feb 10PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Nov 11PetMed Express Puts Are Compelling
Aug 25PetMed Express CFO to leave post today, by remain with company over transition period
Aug 02PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30
Jul 29PetMed Express FQ1 2023 Earnings Preview
Jul 24PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform
Jul 15Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture
Jul 04PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
May 26Shareholder Returns
| PETS | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | -9.8% | -5.3% | -3.5% |
| 1Y | -33.9% | 13.6% | 22.1% |
Return vs Industry: PETS underperformed the US Specialty Retail industry which returned 13.6% over the past year.
Return vs Market: PETS underperformed the US Market which returned 22.1% over the past year.
Price Volatility
| PETS volatility | |
|---|---|
| PETS Average Weekly Movement | 13.7% |
| Specialty Retail Industry Average Movement | 7.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PETS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PETS's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 287 | Sandra Campos | www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
| PETS fundamental statistics | |
|---|---|
| Market cap | US$105.23m |
| Earnings (TTM) | -US$963.00k |
| Revenue (TTM) | US$259.34m |
0.4x
P/S Ratio-106.5x
P/E RatioIs PETS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETS income statement (TTM) | |
|---|---|
| Revenue | US$259.34m |
| Cost of Revenue | US$188.00m |
| Gross Profit | US$71.34m |
| Other Expenses | US$72.31m |
| Earnings | -US$963.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.047 |
| Gross Margin | 27.51% |
| Net Profit Margin | -0.37% |
| Debt/Equity Ratio | 0% |
How did PETS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 22:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PetMed Express, Inc. is covered by 18 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erin Wilson Wright | BofA Global Research |
| David Westenberg | CL King & Associates, Inc. |
| Kevin Ellich | Craig-Hallum Capital Group LLC |